Osteoporosis

An FDA Rejection Prompts NicOx To Shutter US HQ

2 Comments

By Ed Silverman // August 4th, 2010 // 7:01 am

Merck To Pay $8M In Damages In Fosamax Trial

10 Comments

By Ed Silverman // June 25th, 2010 // 3:33 pm

Wellpoint, Comparative Effectiveness And Boniva

10 Comments

By Ed Silverman // June 25th, 2010 // 8:57 am

Amgen Wins FDA Approval For Prolia

1 Comment

By Ed Silverman // June 1st, 2010 // 4:54 pm

Merck Wins Second Fosamax Trial

4 Comments

By Ed Silverman // May 5th, 2010 // 4:32 pm

A Bad Break: FDA Continues Review Of Bone Drugs

5 Comments

By Ed Silverman // March 11th, 2010 // 8:42 am

Boning Up On How Merck Marketed Fosamax

25 Comments

By Ed Silverman // December 23rd, 2009 // 10:11 am

Brittle Bets: Amgen’s Osteoporosis Drug Delivers

Make a comment

By Ed Silverman // September 16th, 2008 // 10:45 am

Amgen’s Osteoporosis Drug: Make Or Break

1 Comment

By Ed Silverman // September 12th, 2008 // 5:02 pm

FDA Panel Backs Pfizer Osteoporosis Drug

2 Comments

By Ed Silverman // September 8th, 2008 // 5:10 pm

« Newer Posts
Older posts »

Clear

Clear

All rights reserved, UBM Canon. Copyright, UBM Canon.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/